Cancers after hematopoietic cell transplantation for aplastic anemia—the importance of persistence - Top-Institutions - MDSpire

Cancers after hematopoietic cell transplantation for aplastic anemia—the importance of persistence

  • By

  • Alicia Rovó

  • André Tichelli

  • November 9, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #4

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Hematology
    • Cancer Epidemiology

  • #5

    University of Washington Medical Center
    University of Washington Medical Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Oncology

Original Source(s)

Cancers after hematopoietic cell transplantation for aplastic anemia—the importance of persistence

  • by Alicia Rovó, André Tichelli

  • November 9, 2021

Related Content

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer

Hodgkin lymphoma with hypereosinophilia in a pediatric patient: case report and review of the literature

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min